Notice: Images are for illustration only and may not reflect the exact product you receive. Brand-name medications may look different depending on their country of origin—Canadian versions, for example, often include a "PR" symbol on the packaging. Rest assured, the medication, dosage, and active ingredients will be exactly as prescribed. Canada Pharmacy Store is committed to your health and safety, and we work only with licensed pharmacies to ensure you receive trusted, high-quality medication every time.
General Medication Fact Sheet for Opzelura
| Field | Information |
|---|---|
| Medication Name | Opzelura |
| Generic Name | Ruxolitinib |
| Boxed/Label Warning | Increased risk of serious infections, mortality in JAK inhibitor trials, malignancy, major adverse cardiovascular events (MACE), thrombosis. |
| Purpose | Treatment of atopic dermatitis (eczema) and vitiligo. |
| Mechanism of Action | Janus kinase (JAK) inhibitor; inhibits JAK1 and JAK2 enzymes, reducing inflammatory pathways. |
| Dosage Forms | Topical cream |
| Available Strengths | 1.5% |
| Dosage Frequency | Twice daily |
| Common Side Effects | Application site reactions (e.g., acne, itching, irritation), nasopharyngitis. |
| Serious Side Effects | Serious infections (including opportunistic infections), malignancy, thrombosis, elevated cholesterol. |
| Drug Interactions | Avoid use with other JAK inhibitors, strong immunosuppressants, or biologic therapies. Consult healthcare provider for potential interactions. |
| Important Notes | For topical use only. Avoid contact with eyes. Wash hands after application. Do not use occlusive dressings unless directed by a healthcare provider. Monitor for signs and symptoms of infection. |
| Storage | Store at room temperature, away from heat and light. |
| Missed Dose | Apply as soon as you remember. If it is almost time for your next application, skip the missed dose and apply the next dose at the regularly scheduled time. Do not apply extra cream to make up for the missed dose. |
| Alternatives | Topical corticosteroids, Topical calcineurin inhibitors (tacrolimus, pimecrolimus), Crisaborole (Eucrisa), Phototherapy |
Opzelura Alternatives
| Medication | Mechanism of Action | Notes |
|---|---|---|
| Tacrolimus (Protopic) | Calcineurin inhibitor that reduces inflammation. | Non-steroidal alternative to corticosteroids; may cause burning sensation initially. |
| Pimecrolimus (Elidel) | Calcineurin inhibitor that reduces inflammation. | Non-steroidal alternative to corticosteroids; generally milder than Tacrolimus. |
| Crisaborole (Eucrisa) | Phosphodiesterase 4 (PDE4) inhibitor; reduces inflammation. | Non-steroidal cream for mild to moderate atopic dermatitis. |
Opzelura Side Effects
| Common Side Effects | Serious Side Effects |
|---|---|
| Application site acne | Serious infections (including herpes zoster) |
| Application site pruritus (itching) | Malignancy (lymphoma, skin cancer) |
| Application site irritation | Thrombosis (blood clots) |
| Nasopharyngitis (common cold) | Elevated cholesterol |
| Folliculitis | Major Adverse Cardiovascular Events (MACE) |
Opzelura Dosage Guide
| Condition | Starting Dose | Maintenance Dose | Administration Notes |
|---|---|---|---|
| Atopic Dermatitis | Apply a thin layer to affected areas twice daily. | Apply a thin layer to affected areas twice daily. | Use on up to 20% of body surface area. Do not bandage or cover treated skin unless directed by your doctor. |
| Vitiligo | Apply a thin layer to affected areas twice daily. | Apply a thin layer to affected areas twice daily. | Use with sun protection. Visible repigmentation may take up to 24 weeks. |
Opzelura Price With And Without Insurance
| Purchase Context | Estimated Price |
|---|---|
| With Insurance | $50 |
| Without Insurance (U.S.) | $2300 |
| From Canada | $2100 |
